ABSTRACT This study determined the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV ) and associated risk factors among blood donors in Aden city, Yemen. A systematic sample of 469 male blood donors was selected from those attending the national blood bank service in Aden between June and October 2007. Data were collected by questionnaire and blood samples collected. Of the 469 participants, 24 (5.1%) were positive for HBsAg and 6 (1.3%) for anti-HCV. In multivariate analysis, history of: blood transfusion (OR = 22.8), dental treatment (OR = 3.6), cupping (OR = 3.9) and malaria infection (OR = 6.8) were significantly associated with being positive for HBsAg. Those with history of blood donation were less likely to be positive for HBsAg (OR = 0.17). Those with a history of blood donation were significantly less likely to be positive for anti-HCV positivity (OR = 0.05), while those with history of blood transfusion were more likely to test positive (OR = 65.6). The prevalence of HBV and HCV among blood donors in Yemen is still high compared to many other countries. 
Introduction
Infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) causes considerable morbidity and mortality worldwide [1, 2] . In Yemen, chronic hepatitis is an important cause of cirrhosis and liver cancer but studies on the prevalence of these viruses in the general population are scarce [3] . Among Middle Eastern countries, Bahrain, Islamic Republic of Iran and Kuwait have low HBV endemicity; Cyprus, Iraq and United Arab Emir ates have intermediate endemicity; while Egypt, Jordan, Oman, Palestine, Yemen and Saudi Arabia have high endemicity [4] . In 1988 a sero epidemiological survey of hepatitis A, B and D was performed in the Yemen [5] . The prevalence of hepatitis B surface antigen (HBsAg) was 12.7%. Using multivariate analysis, age, past history of jaundice, and combined his tory of blood transfusion and surgery were independent predictors of hepa titis B infection [5] .
The prevalence rates of HBsAg among volunteer blood donors in developing countries are much higher than that reported in developed coun tries [6] . This reflects the efficacy of blood donor selection policies, effective screening and very low HBV preva lence in the general population in these countries. Volunteer blood donors are generally regarded as a healthier seg ment of any community, as blood banks usually have strict selection criteria. [7] . The proportion of donors with hepatitis and the risk factors associated with the disease among these healthy individuals may reflect the magnitude of chronic HBV and HCV infection in the general population.
The awareness of the importance of blood safety for controlling the transmission of HBV and HCV has helped to decrease the spread of these viruses. Public health interventions and strategies have been shown to be effective method of preventing such infection. Any strategy to pre vent these infections must therefore be based on accurate data, includ ing information about prevalence and risk factors of these infections. Therefore, this study was conducted to determine the prevalence of HBV and HCV and their associated factors among blood donors at Aden city, Yemen. Such information may raise awareness regarding the need for ur gent action to prevent HBV and HCV transmission in Yemen.
Methods

Study population
This study was conducted among all blood donors who attended the nation al blood bank service in Aden in Yemen between June and October 2007. Blood donation operates on an exchange basis in which relatives and friends of patients are requested to donate blood for their clinical management. A systematic sam ple was obtained by selecting all blood donors attending the national blood bank every other day. For cultural rea sons, only males who consider them selves healthy donate blood. The staff at the national blood bank informed donors about their infectious status and those who were found to be infected were counselled and referred to seek medical attention.
Data collection
A structured selfadministered ques tionnaire was used to collect data. The questionnaire was filled through facetoface interview by a trained pub lic health specialist (first author) for those who could not read and write. The questionnaire sought information about personal characteristics such as age, gender, level of education, marital status, number of wives, number of chil dren, residency, occupational history, previous blood donation, and history of: blood transfusion, haemodialysis, cupping, travel outside the country, malaria, hepatitis B vaccination, surgi cal procedures and dental treatment. History of malaria infection was de termined by asking the participants whether they had ever had physician diagnosed malaria.
Laboratory testing
Blood samples were routinely collected from blood donors at the national blood bank. Testing of specimens was performed at the laboratories of virol ogy unit of the national blood bank. Blood was screened for HBsAg using a hepatitis B antigen detection kit/en zyme immunoassay (PRC, Germany). Hepatitis C infection was measured with IMx HCV version 3.0 (Abott, Ger many). Manufacturer's instructions were followed.
Ethical considerations
Written consent was obtained from the respondents who agreed to participate in this study. The respondents were as sured about the confidentiality of the information and that the laboratory results would not be disclosed to any other persons.
Statistical analysis
Data are presented as frequency dis tributions for categorical variables. Differences in the prevalence of hepa titis between patients according to the variables examined were tested with the Pearson chisquared test. Multivariate analysis using binary logistic regression was used to identify factors associated with HBsAg and antiHCV. Data were analysed using SPSS, version 11.5. A Pvalue of less than 0.05 was considered statistically significant. 
Results
Participant's characteristics
Prevalence of HBV and HCV
Of the 469 Yemeni blood donors, 24 (5.1%) were positive for HBsAg and 6 (1.3%) where positive for antiHCV. The prevalence of positive HBsAg and positive antiHCV according to socio demographic and relevant characteris tics is shown in Table 2 . There was no difference in the prevalence of hepatitis B and hepatitis C in donors according to their sociodemographic status. The prevalence of hepatitis B and hepatitis C was significantly lower among those with history of blood donations (P = 0.01) and higher among those with a history of blood transfusion (P = 0.01), dental treatment (P = 0.01), cupping (P = 0.04) and malaria infection (P = 0.04).
Multivariate analysis
In the multivariate analysis (Table 3) , after adjustment for all other variables, history of blood transfusion (OR = 22.8), dental treatment (OR = 3.6), cupping (OR=3.9) and malaria infec tion (OR = 6.8) remained significantly associated with increased odds of being positive for HBsAg. Those with history of blood donation were significantly less likely to be positive for HBsAg.
The odds of having positive anti HCV differed significantly between participants according to the history of blood donation and history of blood transfusion. Frequent blood donors were less likely to test positive for Anti HCV whereas those with history of blood transfusion were more likely to test positive for antiHCV.
Discussion
The prevalence of hepatitis B among blood donors at the national blood bank service in Aden Governorate, Yemen found in this study was 5.1%. Much higher rates (7.1%, 9.8%, 15% and 6.7 %) have previously been reported among Yemeni blood donors [8] [9] [10] . These differences in the prevalence rates might be explained by the geographical differences in the availability of services and programmes or might reflect a true reduction in prevalence over time. The prevalence of HBsAg in the general population seems to be relatively high in Yemen. In a seroepidemiological survey of hepatitis in Yemen in 1988, Scott et al. reported a prevalence of HBsAg of 12.7% [5] . Although it is dif ficult to compare the prevalence rates reported in our study (among blood donors) with that reported by Scott et al. (among the general population), it seems that the rate of HBsAg has decreased dramatically. Introducing hepatitis B vaccine within the national immunization programmes, improve ment of the people's knowledge about hepatitis risk factors through educa tional programmes, and the availabil ity of measures to diagnose hepatitis in health centres and blood banks might explain this decrease. Many other stud ies in nearby countries have shown a lower prevalence of hepatitis B among blood donors, including Saudi Arabia (4.0%) [11] , Egypt (4.3%) [12] and Pakistan (3.3%) [13] . This may be be cause there was insufficient protection for patients admitted to hospitals in Yemen. Sterilization, disinfection and general standards of training and pro ficiency are generally lacking in most hospitals in Yemen. Our study demonstrated that no previous blood donation, history of blood transfusion, history of dental procedures, history of cupping and previous infection with malaria were associated with increased odds of hepatitis B infection. The significant association between HBsAg positiv ity and history of blood transfusion, cupping and dental treatment is consistent with the findings of other studies [14, 15] . The association be tween previous infection with malar ia and HBsAg positivity (OR = 6.8) may relate to impaired clearance of liver parasites in the presence of the reduced level of HLA class I antigen expression on hepatocytes infected by HBV [16] . In a case-control study in Gambia, the prevalence of HBV was significantly increased amongst children with severe Plasmodium falciparum malaria compared to matched controls [16] . Barcus et al. found a prevalence of HBV infection of 24% in adult Vietnamese patients admit ted with severe P. falciparum malaria, which was higher than the estimated 10% prevalence of HBV in that area [17] .Previous studies have shown that the prevalence rates of malaria in Yemen ranged between 12.8% and 18.6% [18] [19] [20] and males are more infected [20] . The association between HBV positivity and malaria may relate to impaired clearance of the liverstage malaria parasites, as a result of HBV infection of the hepatocytes. Also, protein levels in the body may reflect the immunity status of an individual; hence, any adverse influence may increase the vulnerability to hepatitis B infection.
We found that 1.3% of the blood donors were positive for antiHCV. A similar study among blood donors in Yemen reported that about 1.1% of the donors in Hajja Governorate were infected with hepatitis C [10] . Sallam et al. reported a prevalence of hepatitis C in 2003 of 0.2 % in Sana'a and 0.6 % in Aden [9] . The prevalence of hepatitis C among blood donors is higher than that reported from the neighbouring countries including Oman (0.5%) and Saudi Arabia (1.0% ) [21, 22] . Such small differences in prevalence rates may be explained by methodological differences between studies.
Only history of blood donation and blood transfusion were signifi cantly associated with HCV infec tion in our study. Firsttime blood donors were 20 times more likely to have HCV infection compared with frequent donors. This association is plausible since firsttime blood donors have never been screened. The lack of an associations between HCV in fection and other variables, including malaria, may be explained by the fact that only 6 people were positive for antiHCV.
The seroprevalence rates of hepati tis B and hepatitis C are high in Yemen and nationwide efforts are required to identify infected individuals. Trans mission of hepatitis B and C through unscreened blood transfusion, reuse of unsterilized syringes and medical equipment is well documented in the pertinent literature. Moreover, peo ple having cupping, history of dental treatment, circumcision and shaving by barbers are also at increased risk due to reuse of equipment. Efforts should be made for the promotion of behaviour changes among the public and health care workers to use sterilized medical instruments and screened blood.
In conclusion, the prevalence of hepatitis B and C among blood do nors in Yemen is still high compared to many other countries. Given the lack of information on the preva lence of hepatitis B and C in the general population in Yemen, we recommend a populationbased study for the assessment of hepatitis B and C prevalence as a first step to implement control measures. Increased coverage of hepatitis B vaccination would further reduce that rate. ‫املتوسط‬ ‫لرشق‬ ‫الصحية‬ ‫املجلة‬ ‫عرش‬ ‫الثامن‬ ‫املجلد‬ ‫السادس‬ ‫العدد‬
